 |
|
|
Quick Help |
 |
|
 |
|
Services |
 |
|
 |
|
 |
Queries |
 |
Tel1: +91 79 65123395 |
Tel2: +91 79 26463395 |
Email: click here |
 |
|
 |
 |
 |
|
 |
(R,Z)-5-chloro-2-isopropyl-N,Ndimethylpent-4-enamide |
|
(R,Z)-5-chloro-2-isopropyl-N,Ndimethylpent-4-enamide |
Manus Aktteva Biopharma LLP offers Aliskiren Isomer, (R,Z)-5-chloro-2-isopropyl-N,Ndimethylpent-4-enamide, for your requirements of RND, with supportive technical documents. |
Product Reference ID: MA- ZO-1023-O |
 |
|
Chemical Name: |
(R,Z)-5-chloro-2-isopropyl-N,Ndimethylpent-4-enamide |
|
 |
Description |
CAS number |
Not Reported |
Synonym |
(R,Z)-5-chloro-2-isopropyl-N,Ndimethylpent-4-enamide |
Specifications |
Available on request |
Packing |
Export worthy packing |
Application |
Aliskiren hemifumarate Isomer |
Material Safety Data Sheet
|
Available on request
|
Availability |
For RND |
|
 |
|
 |
 |
|
 |
Aliskiren hemifumarate Isomer, Aliskiren hemifumarate Isomers, Aliskiren hemifumarate Impurities, Aliskiren hemifumarate Impurity, India, China, RND |
|
|
|
|
 |
NOTE:
- Manus Aktteva Biopharma LLP, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|